25 XP   0   0   10

Yield10 Bioscience Inc
Buy, Hold or Sell?

Let's analyse Yield10 Bioscience Inc together

PenkeI guess you are interested in Yield10 Bioscience Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Yield10 Bioscience Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Yield10 Bioscience Inc

I send you an email if I find something interesting about Yield10 Bioscience Inc.

Quick analysis of Yield10 Bioscience Inc (30 sec.)










What can you expect buying and holding a share of Yield10 Bioscience Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$0.03
Expected worth in 1 year
$-0.54
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
$-0.57
Return On Investment
-150.0%

For what price can you sell your share?

Current Price per Share
$0.38
Expected price per share
$0.24 - $1.63
How sure are you?
50%

1. Valuation of Yield10 Bioscience Inc (5 min.)




Live pricePrice per Share (EOD)

$0.38

Intrinsic Value Per Share

$-10.49 - $-2.95

Total Value Per Share

$-10.46 - $-2.92

2. Growth of Yield10 Bioscience Inc (5 min.)




Is Yield10 Bioscience Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$392k$11.6m-$10m-616.5%

How much money is Yield10 Bioscience Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.6m-$3.3m-$307.7k-8.5%
Net Profit Margin-2,517.5%-2,670.5%--

How much money comes from the company's main activities?

3. Financial Health of Yield10 Bioscience Inc (5 min.)




4. Comparing to competitors in the Agricultural Inputs industry (5 min.)




  Industry Rankings (Agricultural Inputs)  


Richest
#154 / 159

Most Revenue
#149 / 159

Most Profit
#136 / 159

Most Efficient
#156 / 159

What can you expect buying and holding a share of Yield10 Bioscience Inc? (5 min.)

Welcome investor! Yield10 Bioscience Inc's management wants to use your money to grow the business. In return you get a share of Yield10 Bioscience Inc.

What can you expect buying and holding a share of Yield10 Bioscience Inc?

First you should know what it really means to hold a share of Yield10 Bioscience Inc. And how you can make/lose money.

Speculation

The Price per Share of Yield10 Bioscience Inc is $0.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Yield10 Bioscience Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Yield10 Bioscience Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.03. Based on the TTM, the Book Value Change Per Share is $-0.14 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Yield10 Bioscience Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.31-81.8%-0.30-79.5%-0.28-72.7%-0.25-66.8%-0.31-81.5%
Usd Book Value Change Per Share-0.02-4.3%-0.14-37.5%-0.24-61.9%-0.03-7.6%-0.06-15.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.8%
Usd Total Gains Per Share-0.02-4.3%-0.14-37.5%-0.24-61.9%-0.03-7.6%-0.06-14.5%
Usd Price Per Share0.33-1.74-3.87-3.83-2.69-
Price to Earnings Ratio-0.26--1.44--3.56--4.33--2.80-
Price-to-Total Gains Ratio-20.07--21.29--16.85--14.67--6.07-
Price to Book Ratio9.99-22.19-4.02-7.87-5.61-
Price-to-Total Gains Ratio-20.07--21.29--16.85--14.67--6.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.38
Number of shares2631
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.14-0.03
Usd Total Gains Per Share-0.14-0.03
Gains per Quarter (2631 shares)-374.85-76.16
Gains per Year (2631 shares)-1,499.41-304.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1499-15090-305-315
20-2999-30080-609-620
30-4498-45070-914-925
40-5998-60060-1219-1230
50-7497-75050-1523-1535
60-8996-90040-1828-1840
70-10496-105030-2132-2145
80-11995-120020-2437-2450
90-13495-135010-2742-2755
100-14994-150000-3046-3060

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%2.071.00.02.7%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%9.031.00.022.5%13.060.00.017.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%1.00.072.01.4%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%9.031.00.022.5%13.060.00.017.8%

Fundamentals of Yield10 Bioscience Inc

About Yield10 Bioscience Inc

Yield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-22 08:21:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Yield10 Bioscience Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Yield10 Bioscience Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Yield10 Bioscience Inc to the Agricultural Inputs industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Yield10 Bioscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2,517.5%+2,517.5%
TTM-2,517.5%YOY-2,670.5%+153.0%
TTM-2,517.5%5Y-2,062.2%-455.2%
5Y-2,062.2%10Y-1,579.0%-483.2%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.9%-4.9%
TTM-2,517.5%4.6%-2,522.1%
YOY-2,670.5%7.8%-2,678.3%
5Y-2,062.2%5.1%-2,067.3%
10Y-1,579.0%4.5%-1,583.5%
1.1.2. Return on Assets

Shows how efficient Yield10 Bioscience Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Yield10 Bioscience Inc to the Agricultural Inputs industry mean.
  • -61.7% Return on Assets means that Yield10 Bioscience Inc generated $-0.62 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Yield10 Bioscience Inc:

  • The MRQ is -61.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -58.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-61.7%TTM-58.9%-2.7%
TTM-58.9%YOY-22.3%-36.7%
TTM-58.9%5Y-26.8%-32.2%
5Y-26.8%10Y-28.0%+1.2%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-61.7%1.0%-62.7%
TTM-58.9%1.2%-60.1%
YOY-22.3%2.3%-24.6%
5Y-26.8%1.3%-28.1%
10Y-28.0%1.2%-29.2%
1.1.3. Return on Equity

Shows how efficient Yield10 Bioscience Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Yield10 Bioscience Inc to the Agricultural Inputs industry mean.
  • -950.5% Return on Equity means Yield10 Bioscience Inc generated $-9.51 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Yield10 Bioscience Inc:

  • The MRQ is -950.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -495.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-950.5%TTM-495.5%-455.0%
TTM-495.5%YOY-31.4%-464.1%
TTM-495.5%5Y-122.0%-373.5%
5Y-122.0%10Y-84.0%-38.0%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-950.5%2.0%-952.5%
TTM-495.5%2.4%-497.9%
YOY-31.4%5.0%-36.4%
5Y-122.0%2.6%-124.6%
10Y-84.0%2.6%-86.6%

1.2. Operating Efficiency of Yield10 Bioscience Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Yield10 Bioscience Inc is operating .

  • Measures how much profit Yield10 Bioscience Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Yield10 Bioscience Inc to the Agricultural Inputs industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Yield10 Bioscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2,523.0%+2,523.0%
TTM-2,523.0%YOY-2,674.4%+151.4%
TTM-2,523.0%5Y-1,826.9%-696.1%
5Y-1,826.9%10Y-1,490.8%-336.1%
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.5%-8.5%
TTM-2,523.0%6.2%-2,529.2%
YOY-2,674.4%10.4%-2,684.8%
5Y-1,826.9%7.7%-1,834.6%
10Y-1,490.8%5.5%-1,496.3%
1.2.2. Operating Ratio

Measures how efficient Yield10 Bioscience Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Agricultural Inputs industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Yield10 Bioscience Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM26.744-26.744
TTM26.744YOY28.032-1.288
TTM26.7445Y22.219+4.524
5Y22.21910Y19.842+2.377
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.552-1.552
TTM26.7441.609+25.135
YOY28.0321.453+26.579
5Y22.2191.574+20.645
10Y19.8421.260+18.582

1.3. Liquidity of Yield10 Bioscience Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Yield10 Bioscience Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Agricultural Inputs industry mean).
  • A Current Ratio of 0.85 means the company has $0.85 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Yield10 Bioscience Inc:

  • The MRQ is 0.850. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.567. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ0.850TTM1.567-0.717
TTM1.567YOY7.554-5.987
TTM1.5675Y5.971-4.404
5Y5.97110Y5.090+0.881
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8501.653-0.803
TTM1.5671.653-0.086
YOY7.5541.690+5.864
5Y5.9711.769+4.202
10Y5.0901.569+3.521
1.3.2. Quick Ratio

Measures if Yield10 Bioscience Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Yield10 Bioscience Inc to the Agricultural Inputs industry mean.
  • A Quick Ratio of 0.71 means the company can pay off $0.71 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Yield10 Bioscience Inc:

  • The MRQ is 0.713. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.603. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.713TTM1.603-0.890
TTM1.603YOY12.294-10.691
TTM1.6035Y8.231-6.628
5Y8.23110Y6.351+1.880
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7130.578+0.135
TTM1.6030.684+0.919
YOY12.2940.711+11.583
5Y8.2310.772+7.459
10Y6.3510.766+5.585

1.4. Solvency of Yield10 Bioscience Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Yield10 Bioscience Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Yield10 Bioscience Inc to Agricultural Inputs industry mean.
  • A Debt to Asset Ratio of 0.94 means that Yield10 Bioscience Inc assets are financed with 93.5% credit (debt) and the remaining percentage (100% - 93.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Yield10 Bioscience Inc:

  • The MRQ is 0.935. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.769. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.935TTM0.769+0.166
TTM0.769YOY0.271+0.499
TTM0.7695Y0.487+0.282
5Y0.48710Y0.397+0.090
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9350.443+0.492
TTM0.7690.444+0.325
YOY0.2710.451-0.180
5Y0.4870.473+0.014
10Y0.3970.476-0.079
1.4.2. Debt to Equity Ratio

Measures if Yield10 Bioscience Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Yield10 Bioscience Inc to the Agricultural Inputs industry mean.
  • A Debt to Equity ratio of 1,441.3% means that company has $14.41 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Yield10 Bioscience Inc:

  • The MRQ is 14.413. The company is unable to pay all its debts with equity. -1
  • The TTM is 6.979. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ14.413TTM6.979+7.434
TTM6.979YOY0.380+6.600
TTM6.9795Y1.935+5.044
5Y1.93510Y1.231+0.705
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
MRQ14.4130.800+13.613
TTM6.9790.800+6.179
YOY0.3800.867-0.487
5Y1.9351.001+0.934
10Y1.2311.032+0.199

2. Market Valuation of Yield10 Bioscience Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Yield10 Bioscience Inc generates.

  • Above 15 is considered overpriced but always compare Yield10 Bioscience Inc to the Agricultural Inputs industry mean.
  • A PE ratio of -0.26 means the investor is paying $-0.26 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Yield10 Bioscience Inc:

  • The EOD is -0.305. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.263. Based on the earnings, the company is expensive. -2
  • The TTM is -1.445. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.305MRQ-0.263-0.043
MRQ-0.263TTM-1.445+1.182
TTM-1.445YOY-3.559+2.114
TTM-1.4455Y-4.326+2.881
5Y-4.32610Y-2.801-1.525
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD-0.3058.982-9.287
MRQ-0.2639.038-9.301
TTM-1.44510.477-11.922
YOY-3.5598.764-12.323
5Y-4.32612.981-17.307
10Y-2.80119.959-22.760
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Yield10 Bioscience Inc:

  • The EOD is -0.436. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.375. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.811. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.436MRQ-0.375-0.061
MRQ-0.375TTM-1.811+1.436
TTM-1.811YOY-4.173+2.362
TTM-1.8115Y-4.844+3.033
5Y-4.84410Y-3.227-1.617
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD-0.4360.533-0.969
MRQ-0.3750.595-0.970
TTM-1.811-1.396-0.415
YOY-4.1730.648-4.821
5Y-4.844-0.014-4.830
10Y-3.2270.142-3.369
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Yield10 Bioscience Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Agricultural Inputs industry mean).
  • A PB ratio of 9.99 means the investor is paying $9.99 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Yield10 Bioscience Inc:

  • The EOD is 11.614. Based on the equity, the company is expensive. -2
  • The MRQ is 9.985. Based on the equity, the company is overpriced. -1
  • The TTM is 22.193. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD11.614MRQ9.985+1.629
MRQ9.985TTM22.193-12.208
TTM22.193YOY4.018+18.176
TTM22.1935Y7.868+14.325
5Y7.86810Y5.610+2.258
Compared to industry (Agricultural Inputs)
PeriodCompanyIndustry (mean)+/- 
EOD11.6141.381+10.233
MRQ9.9851.520+8.465
TTM22.1931.657+20.536
YOY4.0182.385+1.633
5Y7.8681.988+5.880
10Y5.6102.682+2.928
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Yield10 Bioscience Inc.

3.1. Institutions holding Yield10 Bioscience Inc

Institutions are holding 5.099% of the shares of Yield10 Bioscience Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Cannell Peter B & CO Inc2.07090.0019248113-10725-4.1435
2023-12-31Geode Capital Management, LLC0.521606249700
2023-12-31Cutter & CO Brokerage, Inc.0.41730.00335000000
2023-12-31Vanguard Group Inc0.337604045100
2023-12-31Virtu Financial LLC0.30170.00073614420785135.3278
2023-12-31Millennium Management LLC0.2732032734-22530-40.768
2023-12-31BlackRock Inc0.261903138000
2023-09-30Citadel Advisors Llc0.2217026564265640
2023-12-31Warberg Asset Management LLC0.21280.001225500-15494-37.7958
2023-12-31Birchview Capital, LP0.15650.00351875000
2023-12-31XTX Topco Ltd0.12020.000814407144070
2023-12-31Renaissance Technologies Corp0.1194014300143000
2023-12-31HRT FINANCIAL LLC0.1015012165167015.9123
2023-12-31Tower Research Capital LLC0.086010306-146-1.3969
2023-12-31Wells Fargo & Co0.0003036-30-45.4545
2023-12-31IFP Advisors, LLC0.000303000
2023-12-31VIMA LLC0.0001012120
2023-12-31Salem Investment Counselors Inc004133.3333
2023-09-30Concord Wealth Partners000-3500-100
2023-09-30FMR Inc000-1405-100
Total 5.2030.0114623393+23909+3.8%

3.2. Funds holding Yield10 Bioscience Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Fidelity Extended Market Index0.412704944700
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.337604045100
2024-01-31Fidelity Nasdaq Composite Index0.06330758600
2024-01-31Fidelity Series Total Market Index0.04260510600
2023-12-31NT Ext Equity Mkt Idx Fd - L0.02890346000
2023-12-31Northern Trust Extended Eq Market Idx0.02890346000
2023-12-31SSgA U.S. Extended Market Index Class I0.01770211600
2024-02-29State St US Extended Mkt Indx NL Cl C0.01770211600
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.01590190800
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.01280153230.1962
2023-12-31SSgA U.S. Total Market Index Strategy0.00510610-14-2.2436
2024-01-31Spartan Extended Market Index Pool E0.003035800
2023-12-31NT US Market Cap Idx Fd - L0.0027032700
2023-12-31Northern Trust Wilshire 50000.0027032700
2024-02-29Carbon Collective Climate Sol US Eq ETF0.00160.000219100
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.000506200
2023-09-30BlackRock Extended Mkt Composite0.000404900
2023-12-31BlackRock Extended Equity Market K0.000404300
2024-02-29iShares Core S&P Total US Stock Mkt ETF0.00010700
2023-12-31Extended Equity Market Fund M00500
Total 0.99460.0002119161-110.0%

3.3. Insider Transactions

Insiders are holding 18.81% of the shares of Yield10 Bioscience Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-19Jack W SchulerSELL360000.21
2023-12-08Jack W SchulerSELL350000.24
2023-10-06Jack W SchulerSELL379310.3
2023-10-04Jack W SchulerSELL413990.31
2023-08-15Jack W SchulerBUY7650000.65
2023-05-05Jack W SchulerBUY3355702.98

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Yield10 Bioscience Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.016-0.142+775%-0.235+1345%-0.029+78%-0.058+257%
Book Value Per Share--0.0330.136-76%0.975-97%0.707-95%0.830-96%
Current Ratio--0.8501.567-46%7.554-89%5.971-86%5.090-83%
Debt To Asset Ratio--0.9350.769+22%0.271+246%0.487+92%0.397+136%
Debt To Equity Ratio--14.4136.979+107%0.380+3694%1.935+645%1.231+1071%
Dividend Per Share----0%-0%-0%0.003-100%
Eps---0.311-0.302-3%-0.276-11%-0.254-18%-0.3100%
Free Cash Flow Per Share---0.218-0.239+10%-0.230+6%-0.204-6%-0.277+27%
Free Cash Flow To Equity Per Share--0.040-0.161+500%-0.166+512%-0.020+150%-0.033+183%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.950--------
Intrinsic Value_10Y_min---10.495--------
Intrinsic Value_1Y_max---0.799--------
Intrinsic Value_1Y_min---1.107--------
Intrinsic Value_3Y_max---2.017--------
Intrinsic Value_3Y_min---3.298--------
Intrinsic Value_5Y_max---2.773--------
Intrinsic Value_5Y_min---5.441--------
Market Cap4552780.000+14%3914192.70020895463.050-81%46306565.000-92%45940245.925-91%32210349.403-88%
Net Profit Margin----25.1750%-26.7050%-20.6220%-15.7900%
Operating Margin----25.2300%-26.7440%-18.2690%-14.9080%
Operating Ratio---26.744-100%28.032-100%22.219-100%19.842-100%
Pb Ratio11.614+14%9.98522.193-55%4.018+149%7.868+27%5.610+78%
Pe Ratio-0.305-16%-0.263-1.445+450%-3.559+1255%-4.326+1547%-2.801+967%
Price Per Share0.380+14%0.3271.744-81%3.865-92%3.834-91%2.688-88%
Price To Free Cash Flow Ratio-0.436-16%-0.375-1.811+383%-4.173+1013%-4.844+1192%-3.227+761%
Price To Total Gains Ratio-23.348-16%-20.073-21.289+6%-16.853-16%-14.667-27%-6.065-70%
Quick Ratio--0.7131.603-56%12.294-94%8.231-91%6.351-89%
Return On Assets---0.617-0.589-4%-0.223-64%-0.268-57%-0.280-55%
Return On Equity---9.505-4.955-48%-0.314-97%-1.220-87%-0.840-91%
Total Gains Per Share---0.016-0.142+775%-0.235+1345%-0.029+78%-0.055+238%
Usd Book Value--392000.0001630500.000-76%11682000.000-97%8469800.000-95%9949575.000-96%
Usd Book Value Change Per Share---0.016-0.142+775%-0.235+1345%-0.029+78%-0.058+257%
Usd Book Value Per Share--0.0330.136-76%0.975-97%0.707-95%0.830-96%
Usd Dividend Per Share----0%-0%-0%0.003-100%
Usd Eps---0.311-0.302-3%-0.276-11%-0.254-18%-0.3100%
Usd Free Cash Flow---2610000.000-2861250.000+10%-2755750.000+6%-2442300.000-6%-3323850.000+27%
Usd Free Cash Flow Per Share---0.218-0.239+10%-0.230+6%-0.204-6%-0.277+27%
Usd Free Cash Flow To Equity Per Share--0.040-0.161+500%-0.166+512%-0.020+150%-0.033+183%
Usd Market Cap4552780.000+14%3914192.70020895463.050-81%46306565.000-92%45940245.925-91%32210349.403-88%
Usd Price Per Share0.380+14%0.3271.744-81%3.865-92%3.834-91%2.688-88%
Usd Profit---3726000.000-3618500.000-3%-3310750.000-11%-3039500.000-18%-3673600.000-1%
Usd Revenue---36750.000-100%128750.000-100%143200.000-100%393050.000-100%
Usd Total Gains Per Share---0.016-0.142+775%-0.235+1345%-0.029+78%-0.055+238%
 EOD+5 -3MRQTTM+13 -18YOY+11 -205Y+8 -2310Y+11 -22

4.2. Fundamental Score

Let's check the fundamental score of Yield10 Bioscience Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.305
Price to Book Ratio (EOD)Between0-111.614
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.713
Current Ratio (MRQ)Greater than10.850
Debt to Asset Ratio (MRQ)Less than10.935
Debt to Equity Ratio (MRQ)Less than114.413
Return on Equity (MRQ)Greater than0.15-9.505
Return on Assets (MRQ)Greater than0.05-0.617
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Yield10 Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.336
Ma 20Greater thanMa 500.291
Ma 50Greater thanMa 1000.268
Ma 100Greater thanMa 2000.255
OpenGreater thanClose0.368
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Net Working Capital  6,069-2,6613,408-3,235173382555-1,146-591



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets6,042
Total Liabilities5,650
Total Stockholder Equity392
 As reported
Total Liabilities 5,650
Total Stockholder Equity+ 392
Total Assets = 6,042

Assets

Total Assets6,042
Total Current Assets3,362
Long-term Assets2,680
Total Current Assets
Cash And Cash Equivalents 2,817
Other Current Assets 545
Total Current Assets  (as reported)3,362
Total Current Assets  (calculated)3,362
+/-0
Long-term Assets
Property Plant Equipment 2,363
Long-term Assets Other 53
Long-term Assets  (as reported)2,680
Long-term Assets  (calculated)2,416
+/- 264

Liabilities & Shareholders' Equity

Total Current Liabilities3,953
Long-term Liabilities1,697
Total Stockholder Equity392
Total Current Liabilities
Short-term Debt 1,628
Short Long Term Debt 977
Accounts payable 381
Other Current Liabilities 2,921
Total Current Liabilities  (as reported)3,953
Total Current Liabilities  (calculated)5,907
+/- 1,954
Long-term Liabilities
Capital Lease Obligations 2,348
Long-term Liabilities  (as reported)1,697
Long-term Liabilities  (calculated)2,348
+/- 651
Total Stockholder Equity
Common Stock119
Retained Earnings -410,886
Accumulated Other Comprehensive Income -247
Other Stockholders Equity 411,406
Total Stockholder Equity (as reported)392
Total Stockholder Equity (calculated)392
+/-0
Other
Capital Stock119
Cash and Short Term Investments 2,817
Common Stock Shares Outstanding 8,988
Current Deferred Revenue-977
Liabilities and Stockholders Equity 6,042
Net Debt 508
Net Invested Capital 1,369
Net Working Capital -591
Property Plant and Equipment Gross 2,363
Short Long Term Debt Total 3,325



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-31
> Total Assets 
0
0
0
7,510
0
0
0
7,325
22,329
22,044
21,384
127,596
124,185
123,110
122,413
119,004
113,426
108,356
101,124
96,946
88,480
84,016
76,170
97,554
87,674
82,215
74,628
66,771
57,211
99,494
91,407
82,912
73,116
66,933
60,969
53,510
45,562
38,714
32,503
26,738
17,428
11,375
28,792
23,135
16,670
26,925
22,120
17,088
10,600
9,387
13,525
10,748
8,494
6,068
5,572
16,882
14,040
12,011
10,137
12,960
13,095
11,156
9,419
16,718
15,046
13,366
16,646
14,522
27,568
25,210
22,946
20,415
17,104
14,273
11,272
8,085
5,334
5,870
6,042
6,0425,8705,3348,08511,27214,27317,10420,41522,94625,21027,56814,52216,64613,36615,04616,7189,41911,15613,09512,96010,13712,01114,04016,8825,5726,0688,49410,74813,5259,38710,60017,08822,12026,92516,67023,13528,79211,37517,42826,73832,50338,71445,56253,51060,96966,93373,11682,91291,40799,49457,21166,77174,62882,21587,67497,55476,17084,01688,48096,946101,124108,356113,426119,004122,413123,110124,185127,59621,38422,04422,3297,3250007,510000
   > Total Current Assets 
0
0
0
5,426
0
0
0
4,255
18,639
17,601
16,249
123,400
119,662
117,178
114,719
111,546
106,446
102,014
95,397
91,841
83,570
79,250
71,575
93,353
83,785
78,445
70,820
63,256
53,764
77,652
73,931
78,439
70,354
52,608
52,879
48,955
43,753
36,913
30,943
25,231
16,014
10,101
27,270
21,965
15,428
25,468
20,423
14,850
8,099
5,661
10,580
7,860
5,659
3,908
3,484
14,917
12,094
10,104
8,264
6,377
6,738
5,017
3,499
11,684
10,509
8,990
12,361
10,342
22,530
21,185
19,054
16,624
13,375
10,704
7,895
5,018
2,443
3,025
3,362
3,3623,0252,4435,0187,89510,70413,37516,62419,05421,18522,53010,34212,3618,99010,50911,6843,4995,0176,7386,3778,26410,10412,09414,9173,4843,9085,6597,86010,5805,6618,09914,85020,42325,46815,42821,96527,27010,10116,01425,23130,94336,91343,75348,95552,87952,60870,35478,43973,93177,65253,76463,25670,82078,44583,78593,35371,57579,25083,57091,84195,397102,014106,446111,546114,719117,178119,662123,40016,24917,60118,6394,2550005,426000
       Cash And Cash Equivalents 
0
0
0
3,152
0
0
0
1,835
685
15,225
6,185
25,182
19,861
9,034
20,703
22,686
35,655
22,101
27,288
26,194
13,395
9,314
9,775
10,814
13,802
14,167
14,432
12,526
20,047
19,778
17,392
21,277
9,604
48,161
47,823
43,773
37,709
31,678
8,872
19,209
3,606
5,531
25,486
20,046
13,257
22,707
17,894
12,269
5,271
3,708
9,782
7,309
4,875
3,011
2,951
14,487
7,583
3,168
3,306
3,023
6,065
3,252
2,877
5,417
4,295
3,290
2,995
3,423
18,582
15,641
14,618
5,329
2,128
3,180
3,922
2,356
1,809
2,336
2,817
2,8172,3361,8092,3563,9223,1802,1285,32914,61815,64118,5823,4232,9953,2904,2955,4172,8773,2526,0653,0233,3063,1687,58314,4872,9513,0114,8757,3099,7823,7085,27112,26917,89422,70713,25720,04625,4865,5313,60619,2098,87231,67837,70943,77347,82348,1619,60421,27717,39219,77820,04712,52614,43214,16713,80210,8149,7759,31413,39526,19427,28822,10135,65522,68620,7039,03419,86125,1826,18515,2256851,8350003,152000
       Short-term Investments 
0
0
0
1,303
0
0
0
1,339
16,360
647
9,140
96,898
98,264
106,462
92,475
86,640
69,176
78,980
67,320
64,902
68,862
68,292
60,290
81,388
69,037
62,958
55,457
49,048
31,900
56,751
55,301
55,578
56,347
36,029
30,418
29,201
17,197
19,770
16,876
11,511
6,812
0
0
0
0
0
0
0
494
494
0
0
0
0
0
0
3,991
6,486
4,491
2,746
2,746
998
0
5,700
5,475
5,211
8,794
6,279
3,262
4,921
3,904
10,661
10,614
6,978
3,483
1,991
0
0
0
0001,9913,4836,97810,61410,6613,9044,9213,2626,2798,7945,2115,4755,70009982,7462,7464,4916,4863,99100000049449400000006,81211,51116,87619,77017,19729,20130,41836,02956,34755,57855,30156,75131,90049,04855,45762,95869,03781,38860,29068,29268,86264,90267,32078,98069,17686,64092,475106,46298,26496,8989,14064716,3601,3390001,303000
       Net Receivables 
0
0
0
426
0
0
0
461
948
957
181
148
181
1,082
1,079
1,547
1,037
485
390
215
443
1,038
1,031
387
271
506
490
836
1,068
538
777
761
739
1,029
1,321
1,286
1,710
1,155
863
1,235
693
712
481
577
826
575
711
534
529
441
546
188
324
308
237
119
78
72
83
160
124
251
154
92
179
72
204
113
159
114
70
198
182
63
76
30
0
0
0
0003076631821987011415911320472179921542511241608372781192373083241885464415295347115758265774817126931,2358631,1551,7101,2861,3211,0297397617775381,0688364905062713871,0311,0384432153904851,0371,5471,0791,082181148181957948461000426000
       Other Current Assets 
0
0
0
48
0
0
0
124
148
274
245
521
734
600
462
673
578
448
399
530
870
606
479
764
675
814
441
846
749
585
461
823
67,377
1,626
2,028
1,978
2,420
2,039
932
1,948
1,147
1,408
940
1,333
774
1,631
1,443
1,668
1,879
1,116
252
363
460
589
296
311
442
378
384
448
549
516
468
475
560
417
368
527
527
509
462
436
451
483
414
641
634
689
545
5456896346414144834514364625095275273684175604754685165494483843784423112965894603632521,1161,8791,6681,4431,6317741,3339401,4081,1471,9489322,0392,4201,9782,0281,62667,37782346158574984644181467576447960687053039944857867346260073452124527414812400048000
   > Long-term Assets 
0
0
0
2,084
0
0
0
3,070
3,690
4,443
5,135
4,196
4,523
5,932
7,694
7,458
6,980
6,342
5,727
5,105
4,910
4,766
4,595
4,201
3,889
3,770
3,808
3,515
3,447
21,842
17,476
4,473
2,762
14,325
8,090
4,555
1,809
1,801
1,560
1,507
1,414
1,274
1,522
1,170
1,242
1,457
1,697
2,238
2,501
3,726
2,945
2,888
2,835
2,160
2,088
1,965
1,946
1,907
1,873
6,583
6,357
6,139
5,920
5,034
4,537
4,376
4,285
4,180
5,038
4,025
3,892
3,791
3,729
3,569
3,377
3,067
2,891
2,845
2,680
2,6802,8452,8913,0673,3773,5693,7293,7913,8924,0255,0384,1804,2854,3764,5375,0345,9206,1396,3576,5831,8731,9071,9461,9652,0882,1602,8352,8882,9453,7262,5012,2381,6971,4571,2421,1701,5221,2741,4141,5071,5601,8011,8094,5558,09014,3252,7624,47317,47621,8423,4473,5153,8083,7703,8894,2014,5954,7664,9105,1055,7276,3426,9807,4587,6945,9324,5234,1965,1354,4433,6903,0700002,084000
       Property Plant Equipment 
0
0
0
1,384
0
0
0
3,005
3,229
3,536
3,445
3,673
4,000
5,362
7,124
6,890
6,412
5,750
5,135
4,388
4,193
4,077
3,907
3,513
3,172
3,053
3,069
2,776
2,707
2,495
2,260
2,276
2,046
1,845
1,634
1,358
1,120
1,087
891
793
700
560
516
456
528
743
908
905
1,352
2,577
1,796
1,739
1,686
1,633
1,587
1,539
1,526
1,477
1,435
6,151
5,954
5,765
5,557
4,384
4,011
3,857
3,731
3,633
3,593
3,486
3,350
3,244
3,204
3,057
2,903
2,736
2,572
2,514
2,363
2,3632,5142,5722,7362,9033,0573,2043,2443,3503,4863,5933,6333,7313,8574,0114,3845,5575,7655,9546,1511,4351,4771,5261,5391,5871,6331,6861,7391,7962,5771,3529059087435284565165607007938911,0871,1201,3581,6341,8452,0462,2762,2602,4952,7072,7763,0693,0533,1723,5133,9074,0774,1934,3885,1355,7506,4126,8907,1245,3624,0003,6733,4453,5363,2293,0050001,384000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,651
14,521
1,503
0
11,763
5,767
2,508
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
886
0
0
0
0
0
0
0
0
0
0
0000000000886000000000000000000000000000000002,5085,76711,76301,50314,52118,65100000000000000000000000000000
       Other Assets 
0
0
0
700
0
0
0
65
0
907
1,690
523
523
570
570
568
568
592
592
717
717
689
688
688
717
717
739
739
740
19,347
15,216
2,197
716
12,480
6,456
3,197
689
714
669
714
714
714
714
714
714
714
789
1,333
1,149
1,149
1,149
1,149
1,149
527
501
426
420
430
438
432
403
374
363
650
526
519
554
3,259
559
539
542
547
525
512
474
331
0
0
0
0003314745125255475425395593,2595545195266503633744034324384304204265015271,1491,1491,1491,1491,1491,3337897147147147147147147146697146893,1976,45612,4807162,19715,21619,3477407397397177176886886897177175925925685685705705235231,690907065000700000
> Total Liabilities 
0
0
0
46,481
0
0
0
53,882
69,119
71,803
74,956
18,008
18,742
22,485
27,886
29,802
31,118
33,556
34,725
37,855
37,503
41,509
41,826
42,510
41,021
41,774
42,832
43,095
41,751
43,304
43,537
43,449
3,606
4,262
5,077
6,170
4,056
4,117
4,300
6,340
4,053
4,511
4,397
4,339
3,340
3,964
4,342
4,060
3,424
5,245
4,947
4,379
3,933
3,827
3,023
3,380
2,405
2,430
2,809
7,262
6,900
6,702
6,799
20,803
5,717
4,879
4,774
4,990
4,474
4,748
4,458
4,389
3,893
4,002
4,052
3,685
4,191
5,283
5,650
5,6505,2834,1913,6854,0524,0023,8934,3894,4584,7484,4744,9904,7744,8795,71720,8036,7996,7026,9007,2622,8092,4302,4053,3803,0233,8273,9334,3794,9475,2453,4244,0604,3423,9643,3404,3394,3974,5114,0536,3404,3004,1174,0566,1705,0774,2623,60643,44943,53743,30441,75143,09542,83241,77441,02142,51041,82641,50937,50337,85534,72533,55631,11829,80227,88622,48518,74218,00874,95671,80369,11953,88200046,481000
   > Total Current Liabilities 
0
0
0
2,807
0
0
0
2,973
2,521
2,903
2,732
3,221
3,236
4,423
5,323
4,659
3,835
4,094
4,830
4,610
3,994
4,129
4,211
4,562
3,018
5,155
7,068
6,395
4,923
6,222
6,957
7,165
3,305
4,000
4,852
5,984
3,908
3,980
4,300
6,195
3,905
4,361
4,247
4,189
3,190
3,814
4,192
3,910
3,102
4,050
2,978
2,758
2,587
2,759
1,986
2,375
1,432
1,489
1,809
1,641
1,502
1,506
1,754
2,207
2,187
1,462
1,476
1,814
1,421
1,823
1,666
1,733
1,376
1,627
1,826
1,610
2,270
2,470
3,953
3,9532,4702,2701,6101,8261,6271,3761,7331,6661,8231,4211,8141,4761,4622,1872,2071,7541,5061,5021,6411,8091,4891,4322,3751,9862,7592,5872,7582,9784,0503,1023,9104,1923,8143,1904,1894,2474,3613,9056,1954,3003,9803,9085,9844,8524,0003,3057,1656,9576,2224,9236,3957,0685,1553,0184,5624,2114,1293,9944,6104,8304,0943,8354,6595,3234,4233,2363,2212,7322,9032,5212,9730002,807000
       Short-term Debt 
0
0
0
419
0
0
0
63
37
14
-8,017
1,391
1,606
3,644
4,415
-19,985
3,447
3,335
4,378
-28,853
0
0
0
0
0
1,751
0
0
165
0
0
0
0
0
0
0
1,689
0
3,287
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
894
869
865
847
602
473
484
544
457
533
537
577
514
590
605
620
575
591
686
1,628
1,628686591575620605590514577537533457544484473602847865869894000000000000000000003,28701,6890000000165001,75100000-28,8534,3783,3353,447-19,9854,4153,6441,6061,391-8,017143763000419000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
869
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
977
97700000000000000000869000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
1,495
0
0
0
1,299
974
1,301
962
1,604
1,330
504
718
299
148
544
153
858
36
108
45
626
27
5
6
239
4
582
528
512
189
613
240
1,233
92
102
422
579
505
432
368
333
288
384
448
120
181
1,467
229
56
51
70
48
76
80
34
39
117
12
55
51
279
135
150
103
60
111
101
45
83
24
24
104
109
495
467
381
381467495109104242483451011116010315013527951551211739348076487051562291,467181120448384288333368432505579422102921,2332406131895125285824239652762645108368581535441482997185041,3301,6049621,3019741,2990001,495000
       Other Current Liabilities 
0
0
0
728
0
0
0
1,446
1,345
1,423
165
166
165
165
165
165
165
165
165
165
3,718
3,755
3,966
3,911
2,750
1,782
4,520
4,250
2,765
3,430
3,613
3,574
2,749
3,091
3,653
3,684
1,155
3,349
141
4,947
2,630
3,202
3,574
3,709
2,653
3,184
3,590
3,513
2,654
1,701
2,749
2,702
2,536
2,689
1,938
2,299
1,352
1,455
1,770
630
570
586
856
1,275
710
828
829
1,109
777
1,185
1,044
1,136
762
998
1,102
926
1,184
1,375
2,921
2,9211,3751,1849261,1029987621,1361,0441,1857771,1098298287101,2758565865706301,7701,4551,3522,2991,9382,6892,5362,7022,7491,7012,6543,5133,5903,1842,6533,7093,5743,2022,6304,9471413,3491,1553,6843,6533,0912,7493,5743,6133,4302,7654,2504,5201,7822,7503,9113,9663,7553,7181651651651651651651651651661651,4231,3451,446000728000
   > Long-term Liabilities 
0
0
0
43,674
0
0
0
50,909
66,598
68,900
72,224
14,787
15,506
18,062
22,563
25,143
27,283
29,462
29,895
33,245
33,509
37,380
37,615
37,948
38,003
36,619
35,764
36,700
36,828
37,082
36,580
36,284
301
262
225
186
148
137
0
145
148
150
150
150
150
150
150
150
322
1,195
1,969
1,621
1,346
1,068
1,037
1,005
973
941
1,000
5,621
5,398
5,196
5,045
18,596
3,530
3,417
3,298
3,176
3,053
2,925
2,792
2,656
2,517
2,375
2,226
2,075
1,921
2,813
1,697
1,6972,8131,9212,0752,2262,3752,5172,6562,7922,9253,0533,1763,2983,4173,53018,5965,0455,1965,3985,6211,0009419731,0051,0371,0681,3461,6211,9691,195322150150150150150150150148145013714818622526230136,28436,58037,08236,82836,70035,76436,61938,00337,94837,61537,38033,50933,24529,89529,46227,28325,14322,56318,06215,50614,78772,22468,90066,59850,90900043,674000
       Other Liabilities 
0
0
0
4,379
0
0
0
6,901
0
7,457
10,782
14,787
15,506
18,062
22,563
25,143
27,283
29,462
29,895
33,245
33,509
37,380
37,615
37,948
38,003
36,619
35,764
36,700
36,828
37,082
36,580
36,284
301
262
225
186
148
137
0
145
148
150
150
150
150
150
150
150
322
1,195
1,969
1,621
1,346
1,068
1,037
1,005
973
941
1,000
935
0
0
0
14,977
18
17
15
13
12
10
9
7
5
0
0
0
0
0
0
00000057910121315171814,9770009351,0009419731,0051,0371,0681,3461,6211,9691,195322150150150150150150150148145013714818622526230136,28436,58037,08236,82836,70035,76436,61938,00337,94837,61537,38033,50933,24529,89529,46227,28325,14322,56318,06215,50614,78710,7827,45706,9010004,379000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,969
36,462
36,165
179
138
97
55
14
0
0
0
0
0
0
0
0
0
0
619
0
0
0
622
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000622000619000000000014559713817936,16536,46236,96900000000000000000000000000000
> Total Stockholder Equity
0
0
0
-38,971
0
0
0
-46,558
-46,791
-49,759
-53,572
109,588
105,443
100,625
94,527
89,202
82,308
74,800
66,399
59,091
50,977
42,507
34,344
55,044
46,653
40,441
31,796
23,676
15,460
56,190
47,870
39,463
69,510
62,671
55,892
47,340
41,506
34,597
28,203
20,398
13,375
6,864
24,395
18,796
13,330
22,961
17,778
13,028
7,176
4,142
8,578
6,369
4,561
2,241
2,549
13,502
11,635
9,581
7,328
5,698
6,195
4,454
2,620
-4,085
9,329
8,487
11,872
9,532
23,094
20,462
18,488
16,026
13,211
10,271
7,220
4,400
1,143
587
392
3925871,1434,4007,22010,27113,21116,02618,48820,46223,0949,53211,8728,4879,329-4,0852,6204,4546,1955,6987,3289,58111,63513,5022,5492,2414,5616,3698,5784,1427,17613,02817,77822,96113,33018,79624,3956,86413,37520,39828,20334,59741,50647,34055,89262,67169,51039,46347,87056,19015,46023,67631,79640,44146,65355,04434,34442,50750,97759,09166,39974,80082,30889,20294,527100,625105,443109,588-53,572-49,759-46,791-46,558000-38,971000
   Common Stock
0
0
0
22
0
0
0
22
25
21
21
206
211
222
224
226
226
229
229
230
230
230
230
265
266
269
269
269
269
341
341
341
341
342
343
343
344
345
345
346
349
350
851
1,352
1,353
270
270
273
274
278
281
283
284
29
35
91
100
100
100
100
125
125
125
9
19
20
33
33
49
49
49
49
49
49
49
49
51
61
119
119615149494949494949493333201991251251251001001001009135292842832812782742732702701,3531,3528513503493463453453443433433423413413413412692692692692662652302302302302292292262262242222112062121252200022000
   Retained Earnings Total Equity000000000-380,753-377,661-375,100-372,458-370,290-368,494-364,894-358,051-356,069-354,198-351,923-350,063-347,433-345,043-342,753-340,201-338,176-335,449-333,357-331,425-335,449-332,251-325,753-319,8360-307,915-302,072-295,820-287,928-280,692-272,538-263,911-256,660-248,795-242,032-232,515-224,770-216,822-245,662-236,059-226,49900000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-2,094
0
0
0
-2,407
-2,597
-105
-88
-184
-159
93
172
236
397
44
143
446
280
135
78
22
9
9
-8
-15
-2
-27
-32
-12
-23
-35
-20
-21
-43
-59
-59
-71
-98
-103
-212
-64
-68
-70
-72
-72
-76
-78
-81
-84
-85
-84
-81
-85
-89
-99
-105
-110
-115
-118
-124
-126
-159
-167
-168
-159
-159
-153
-170
-175
-193
-220
-234
-229
-232
-244
-247
-247-244-232-229-234-220-193-175-170-153-159-159-168-167-159-126-124-118-115-110-105-99-89-85-81-84-85-84-81-78-76-72-72-70-68-64-212-103-98-71-59-59-43-21-20-35-23-12-32-27-2-15-89922781352804461434439723617293-159-184-88-105-2,597-2,407000-2,094000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
282,375
283,620
284,796
286,014
287,134
288,084
289,050
290,000
290,971
291,828
292,661
293,816
294,545
319,575
319,580
319,960
0
337,416
338,580
339,229
339,391
339,803
339,527
339,811
340,472
342,796
355,431
356,667
357,013
357,396
357,646
360,383
360,516
360,670
360,926
377,963
378,924
384,465
384,758
400,865
401,319
0
0
0
0
0
0
0
0
0
000000000401,319400,865384,758384,465378,924377,963360,926360,670360,516360,383357,646357,396357,013356,667355,431342,796340,472339,811339,527339,803339,391339,229338,580337,4160319,960319,580319,575294,545293,816292,661291,828290,971290,000289,050288,084287,134286,014284,796283,620282,37500000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000-35-350-35000-35000
   Other Stockholders Equity 
0
0
0
5,650
0
0
0
6,001
6,256
4,835
-56,207
175,803
176,316
178,902
181,021
182,852
184,245
186,012
187,240
188,532
189,693
191,040
192,351
222,831
224,254
227,582
228,945
230,299
231,710
282,375
283,620
284,796
286,014
287,134
288,084
289,050
290,000
290,971
291,828
292,661
293,816
294,545
319,575
319,580
319,960
336,749
337,416
338,580
339,229
339,391
339,803
339,527
339,811
340,472
342,796
355,340
356,667
357,013
357,396
357,646
360,383
360,516
360,670
360,926
362,917
365,558
367,819
384,758
400,865
401,319
401,760
402,283
402,817
403,347
403,799
404,277
404,803
407,930
411,406
411,406407,930404,803404,277403,799403,347402,817402,283401,760401,319400,865384,758367,819365,558362,917360,926360,670360,516360,383357,646357,396357,013356,667355,340342,796340,472339,811339,527339,803339,391339,229338,580337,416336,749319,960319,580319,575294,545293,816292,661291,828290,971290,000289,050288,084287,134286,014284,796283,620282,375231,710230,299228,945227,582224,254222,831192,351191,040189,693188,532187,240186,012184,245182,852181,021178,902176,316175,803-56,2074,8356,2566,0010005,650000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue450
Cost of Revenue--
Gross Profit-450
 
Operating Income (+$)
Gross Profit-
Operating Expense-14,824
Operating Income-14,374-14,824
 
Operating Expense (+$)
Research Development8,251
Selling General Administrative6,270
Selling And Marketing Expenses-
Operating Expense14,82414,521
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-14,374
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-14,363-14,385
EBIT - interestExpense = 0
-14,492
-14,492
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--14,363
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-14,363
Tax Provision-129
Net Income From Continuing Ops-14,492-14,492
Net Income-14,492
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net110
 

Technical Analysis of Yield10 Bioscience Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Yield10 Bioscience Inc. The general trend of Yield10 Bioscience Inc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Yield10 Bioscience Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Yield10 Bioscience Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.719 < 1.5327 < 1.63.

The bearish price targets are: 0.29 > 0.24 > 0.24.

Tweet this
Yield10 Bioscience Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Yield10 Bioscience Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Yield10 Bioscience Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Yield10 Bioscience Inc. The current macd is 0.02997072.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Yield10 Bioscience Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Yield10 Bioscience Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Yield10 Bioscience Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Yield10 Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) ChartYield10 Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Yield10 Bioscience Inc. The current adx is 43.48.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Yield10 Bioscience Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Yield10 Bioscience Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Yield10 Bioscience Inc. The current sar is 0.26794352.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Yield10 Bioscience Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Yield10 Bioscience Inc. The current rsi is 63.34. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Yield10 Bioscience Inc Daily Relative Strength Index (RSI) ChartYield10 Bioscience Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Yield10 Bioscience Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Yield10 Bioscience Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Yield10 Bioscience Inc Daily Stochastic Oscillator ChartYield10 Bioscience Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Yield10 Bioscience Inc. The current cci is 118.20.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Yield10 Bioscience Inc Daily Commodity Channel Index (CCI) ChartYield10 Bioscience Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Yield10 Bioscience Inc. The current cmo is 30.64.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Yield10 Bioscience Inc Daily Chande Momentum Oscillator (CMO) ChartYield10 Bioscience Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Yield10 Bioscience Inc. The current willr is -70.77244259.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Yield10 Bioscience Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Yield10 Bioscience Inc Daily Williams %R ChartYield10 Bioscience Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Yield10 Bioscience Inc.

Yield10 Bioscience Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Yield10 Bioscience Inc. The current atr is 0.06761567.

Yield10 Bioscience Inc Daily Average True Range (ATR) ChartYield10 Bioscience Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Yield10 Bioscience Inc. The current obv is 252,924,512.

Yield10 Bioscience Inc Daily On-Balance Volume (OBV) ChartYield10 Bioscience Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Yield10 Bioscience Inc. The current mfi is 94.76.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Yield10 Bioscience Inc Daily Money Flow Index (MFI) ChartYield10 Bioscience Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Yield10 Bioscience Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Yield10 Bioscience Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Yield10 Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.336
Ma 20Greater thanMa 500.291
Ma 50Greater thanMa 1000.268
Ma 100Greater thanMa 2000.255
OpenGreater thanClose0.368
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Yield10 Bioscience Inc with someone you think should read this too:
  • Are you bullish or bearish on Yield10 Bioscience Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Yield10 Bioscience Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Yield10 Bioscience Inc

I send you an email if I find something interesting about Yield10 Bioscience Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Yield10 Bioscience Inc.

Receive notifications about Yield10 Bioscience Inc in your mailbox!